Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Tacrolimus in Haploidentical Stem Cell Transplant
NCT06828796Phase 2Recruiting
- Sponsor
- Northside Hospital
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in cytokine release syndrome (CRS), sponsored by Northside Hospital. Started Jul 2025; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
cytokine release syndrome (CRS)
Beyond the preview
Go deeper on NCT06828796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06828796.